IP Library › Granted Patent US 8,591,865
Granted Patent B2
US 8,591,865 · App. 12/946,471 · Granted Nov 26, 2013

Renal function analysis method and apparatus

Inventors: Exing Wang (Carmel, IN); Daniel Meier (Indianapolis, IN); Robert Bunch (Terre Haute, IN); Bruce Molitoris (Indianapolis, IN); Ruben Sandoval (Indianapolis, IN); Matthew Rubin (Indianapolis, IN); Erinn Sheridan (Indianapolis, IN)
Assignee: Pharmacophotonics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,865
App. No.
12/946,471
Granted
Nov 26, 2013
Kind
B2
Abstract

A method for measuring a glomerular filtration rate of a mammalian subject comprises a source of reporter and marker fluorescent molecules. The fluorescent molecules are introduced into the vascular system of the mammalian subject. Over a period of time, a measurement of the intensities of the reporter and marker fluorescent molecules is taken. A ratio is calculated to determine the glomerular filtration rate.

Claims (44)

1. A system for measuring the fluorescence intensity of a reporter fluorescent molecule and a marker fluorescent molecule in a vascular system of a mammalian subject to determine glomerular filtration rate (GFR) of the kidney of the mammalian subject, the system comprising:

a source of said reporter fluorescent molecule and said marker fluorescent molecule;

a means for introducing said reporter fluorescent molecule and said marker fluorescent molecule into the vascular system of the mammalian subject;

a means for measuring the fluorescence intensity of said reporter fluorescent molecule and said marker fluorescent molecule within the vascular system of the mammalian subject;

a means for determining an intensity ratio of the fluorescence intensity of said measured reporter fluorescent molecule and marker fluorescent molecule within the vascular system of the mammalian subject, and

a means for calculating glomerular filtration rate (GFR) of the mammalian subject according to the equation:

G

⁢

⁢

F

⁢

⁢

R

=

V

1

⁡

(

A

2

+

B

2

)

A

2

/

α

+

B

2

/

β

wherein V 1 is plasma volume; A 2 and B 2 are constants; α is a fast phase decay constant; and β is a slow phase decay constant;

wherein the ratio of intensity R(t) of the reporter fluorescent molecule and the marker fluorescent molecule are calculated at predetermined intervals; and

wherein the constants A 2 , B 2 , α and β are calculated by fitting the ratio of intensity data to the following equation:

R ( t )= A 2 e αt +B 2 e −βt

where R(t) is the ratio of intensity as a function of time;

wherein said reporter molecule is filtered by the kidney of the mammalian subject, and said marker molecule is retained in the vascular system of the mammalian subject; and

wherein said reporter molecule and said marker molecule are chemically stable in the vascular system during measurement of kidney function.

2. The system of claim 1 wherein said means for introducing includes a catheter.

3. The system of claim 1 wherein said means for measuring includes an optic fiber in communication with a detector.

4. The system of claim 1 wherein said reporter molecule has a first fluorescent characteristic, and said marker molecule has a second fluorescent characteristic, and wherein said first fluorescent characteristic and second fluorescent characteristic are distinguishable.

5. The system of claim 4 wherein the first fluorescent characteristic is a first excitation wavelength and a first emission wavelength and the second fluorescent characteristic is a second excitation wavelength and a second emission wavelength, said first and second fluorescence excitation wavelengths and said first and second fluorescence emission wavelengths being unequal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2011
From: WANG, EXING, PHD.; MEIER, DANIEL, PHD.; BUNCH, ROBERT, PHD.; MOLITORIS, BRUCE, MD; SANDOVAL, RUBEN; RUBIN, MATTHEW; SHERIDAN, ERINN
To: PHARMACOPHOTONICS, INC.
Reel/Frame 026204/0498 →
Continuity (3)
Continuation In Part 12425827 · Apr 17, 2009
Provisional Application 61046273 · Apr 18, 2008
Related Publication 20110201940A1 · Aug 18, 2011